These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 34680774)
41. Bladder instillation patterns in a cohort of women with interstitial cystitis/bladder pain syndrome. Niino CA; Tholemeier LN; Bresee C; De Hoedt AM; Barbour KE; Kim J; Freedland SJ; Anger JT Urogynecology (Phila); 2023 Nov; 29(11):914-919. PubMed ID: 38107872 [TBL] [Abstract][Full Text] [Related]
42. Purinergic P2X7 receptors as therapeutic targets in interstitial cystitis/bladder pain syndrome; key role of ATP signaling in inflammation. Taidi Z; Mansfield KJ; Bates L; Sana-Ur-Rehman H; Liu L Bladder (San Franc); 2019; 6(1):e38. PubMed ID: 32775480 [TBL] [Abstract][Full Text] [Related]
43. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial. Kuo HC; Jiang YH; Tsai YC; Kuo YC Neurourol Urodyn; 2016 Jun; 35(5):609-14. PubMed ID: 25914337 [TBL] [Abstract][Full Text] [Related]
44. Pentosan polysulfate in patients with bladder pain syndrome/interstitial cystitis with Hunner's lesions or glomerulations: systematic review and meta-analysis. Grigoryan B; Kasyan G; Pivazyan L; Pushkar D Ther Adv Urol; 2022; 14():17562872221102809. PubMed ID: 35677571 [TBL] [Abstract][Full Text] [Related]
45. Myofascial Frequency Syndrome: A novel syndrome of bothersome lower urinary tract symptoms associated with myofascial pelvic floor dysfunction. Ackerman AL; Jackson NJ; Caron AT; Kaufman MR; Routh JC; Lowder JL medRxiv; 2023 Apr; ():. PubMed ID: 37131628 [TBL] [Abstract][Full Text] [Related]
46. Bladder instillations vs onabotulinumtoxinA injection for interstitial cystitis/bladder pain syndrome: a randomized clinical trial. Welch EK; Dengler KL; DiCarlo-Meacham AM; Wheat JE; Pekny CJ; Aden JK; Vaccaro CM Am J Obstet Gynecol; 2024 May; ():. PubMed ID: 38768800 [TBL] [Abstract][Full Text] [Related]
47. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome. Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413 [TBL] [Abstract][Full Text] [Related]
48. Mechanisms of oxidative stress in interstitial cystitis/bladder pain syndrome. Mohammad A; Laboulaye MA; Shenhar C; Dobberfuhl AD Nat Rev Urol; 2024 Jul; 21(7):433-449. PubMed ID: 38326514 [TBL] [Abstract][Full Text] [Related]
49. Animal models of interstitial cystitis/bladder pain syndrome. Tay C; Grundy L Front Physiol; 2023; 14():1232017. PubMed ID: 37731545 [TBL] [Abstract][Full Text] [Related]
52. Intravesical tacrolimus in treatment of intractable interstitial cystitis/bladder pain syndrome - A pilot study. Mishra NN; Riedl C; Shah S; Pathak N Int J Urol; 2019 Jun; 26 Suppl 1():68-72. PubMed ID: 31144739 [TBL] [Abstract][Full Text] [Related]
53. Broaden Horizons: The Advancement of Interstitial Cystitis/Bladder Pain Syndrome. Li J; Yi X; Ai J Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498919 [TBL] [Abstract][Full Text] [Related]
54. Bladder Pain Syndrome and Interstitial Cystitis Beyond Horizon: Reports from the Global Interstitial Cystitis/Bladder Pain Society (GIBS) Meeting 2019 Mumbai - India. Rahnama'i MS; Javan A; Vyas N; Lovasz S; Singh N; Cervigni M; Pandey S; Wyndaele JJ; Taneja R Anesth Pain Med; 2020 Jun; 10(3):e101848. PubMed ID: 32944561 [TBL] [Abstract][Full Text] [Related]
55. A systematic review and meta-analysis on the efficacy of intravesical therapy for bladder pain syndrome/interstitial cystitis. Barua JM; Arance I; Angulo JC; Riedl CR Int Urogynecol J; 2016 Aug; 27(8):1137-47. PubMed ID: 26590137 [TBL] [Abstract][Full Text] [Related]
56. Sexual dysfunction in women with interstitial cystitis/bladder pain syndrome: Do onabotulinum toxin-A injections improve sexual function? Topcuoglu M; Karaburun MC; İbiş A; Gokce Mİ; Süer E; Gülpinar O Neurourol Urodyn; 2023 Mar; 42(3):607-614. PubMed ID: 36708358 [TBL] [Abstract][Full Text] [Related]
57. Pathophysiology, assessment, and treatment of overactive bladder symptoms in patients with interstitial cystitis/bladder pain syndrome. Dobberfuhl AD Neurourol Urodyn; 2022 Nov; 41(8):1958-1966. PubMed ID: 35607890 [TBL] [Abstract][Full Text] [Related]
58. The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis. Jiang YH; Jhang JF; Kuo HC Tzu Chi Med J; 2023; 35(1):31-37. PubMed ID: 36866354 [TBL] [Abstract][Full Text] [Related]
59. Interstitial cystitis/bladder pain syndrome (IC/BPS): Single-center 20 year experience and treatment results in India. Mishra NN Neurourol Urodyn; 2022 Aug; 41(6):1390-1398. PubMed ID: 35598079 [TBL] [Abstract][Full Text] [Related]